5,6-methylenedioxy-2-aminoindane has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies
*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]
*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]
| Studies (5,6-methylenedioxy-2-aminoindane) | Trials (5,6-methylenedioxy-2-aminoindane) | Recent Studies (post-2010) (5,6-methylenedioxy-2-aminoindane) | Studies (3,4-dihydroxyphenylacetic acid) | Trials (3,4-dihydroxyphenylacetic acid) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid) |
|---|---|---|---|---|---|
| 17 | 0 | 12 | 5,410 | 38 | 591 |
| Protein | Taxonomy | 5,6-methylenedioxy-2-aminoindane (IC50) | 3,4-dihydroxyphenylacetic acid (IC50) |
|---|---|---|---|
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 4.17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, XM; Johnson, MP; Nichols, DE | 1 |
1 other study(ies) available for 5,6-methylenedioxy-2-aminoindane and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Brain; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Indans; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Serotonin | 1991 |